Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)

Autor:	Gema Marín Zafra, Silverio Ros Martínez, Pilar Sánchez Henarejos, José Luis Alonso Romero, Agustín Navarrete Montoya
Rok vydání:	2009
Předmět:	Adult Drug Cancer Research Intertrigo medicine.drug_class media_common.quotation_subject Antibiotics Mucocutaneous zone Breast Neoplasms Pharmacology Polyethylene Glycols Pegylated Liposomal Doxorubicin medicine Humans Neoplasm Metastasis Neoplasm Staging media_common Liposome Antibiotics Antineoplastic business.industry General Medicine Dermatologic toxicity enzymes and coenzymes (carbohydrates) Oncology Doxorubicin Toxicity Female lipids (amino acids peptides and proteins) Drug Eruptions Neoplasm Recurrence Local medicine.symptom business
Zdroj:	Clinical and Translational Oncology. 11:486-487
ISSN:	1699-3055 1699-048X
DOI:	10.1007/s12094-009-0390-2
Popis:	Pegylated liposomal doxorubicin (PLD) is a drug whose use is increasingly common. It has been associated with a lower rate of haematologic and cardiac side effects than its nonencapsulated form. However, mucocutaneous toxicity is quite frequent and can be severe. Here we provide a case report of a patient who developed an intertrigolike eruption during treatment with PLD.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5bd8487d8cd8273fe513a6c6f7f274 https://doi.org/10.1007/s12094-009-0390-2 Zobrazit plný text záznamu Full text from SpringerLink